speb/financial-data huggingface dataset:
Financial ratios for ALSOG.PA — annual report dated 2024-12-31
Total revenue: 163563541.6666667
Gross profit: 92753125
Operating income: 7597916.666666667
Net income: 6367708.333333334
Capital expenditures: 1698958.3333333335
Operating cash flow: 17747916.666666668
Depreciation & amortization: 9467708.333333334
Net tangible assets: 27166666.666666668
Owner earnings: 14136458.333333334
Return on net tangible assets (%): 52.03604294478528
Capex to operating income (%): 22.36084452975048
Buffett classification: The Great
Stock price: 16.958333333333336
P/E ratio: 8.138447367904467
Shares outstanding: 3055917
Book value: 66666666.66666666
P/B ratio: 0.7773488868750003
Market cap (USD): 51823259.12500001
Debt to equity: 0.48148437500000013
Current ratio: 1.6891012542831096
Quick ratio: 1.443101442897111
Effective tax rate (%): 7.434887946698971
Interest coverage ratio: 5.872785829307569
COGS to revenue (%): 43.292298482368594
Free cash flow (dilution-adjusted): 15884375.000000002
Buyback yield (%): 0
Inventory turnover: 4.343364641236982
Receivables turnover: 3.1668313736562936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.185296989148366
FCF margin (%): 9.711439871100044
Revenue growth (%): -0.5632307941718728
Rule of 40 score: 9.148209076928172
Financial ratios for ALSOG.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 27166666.666666668
Buffett classification: The Gruesome
Stock price: 16.958333333333336
Shares outstanding: 3055917
Book value: 66666666.66666666
P/B ratio: 0.7773488868750003
Market cap (USD): 51823259.12500001
Debt to equity: 0.48148437500000013
Current ratio: 1.6891012542831096
Quick ratio: 1.443101442897111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSOG.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 28901176.470588237
Buffett classification: The Gruesome
Stock price: 33.6
Shares outstanding: 3055917
Book value: 69524705.88235295
P/B ratio: 1.4768679694057127
Market cap (USD): 102678811.2
Debt to equity: 0.46292473263841877
Current ratio: 1.6573273737141354
Quick ratio: 1.4057909093896868
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMU.AX — annual report dated 2021-12-31
Capital expenditures: 17229.710144927536
Buffett classification: The Gruesome
Stock price: 0.6811594202898551
Shares outstanding: 130268297
Market cap (USD): 88733477.66666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMU.AX — annual report dated 2022-12-31
Operating income: -1268332.4324324324
Net income: -1239138.5135135136
Capital expenditures: 2591179.7297297297
Depreciation & amortization: 804.7297297297297
Net tangible assets: 14258633.108108109
Owner earnings: -3829513.513513514
Return on net tangible assets (%): -26.857507900500487
Buffett classification: The Gruesome
Stock price: 0.2905405405405405
Shares outstanding: 130268297
Book value: 14258633.108108107
P/B ratio: 2.6544074132992073
Market cap (USD): 37848221.425675675
Debt to equity: 0
Current ratio: 6.122460520027721
Quick ratio: 6.122460520027721
Free cash flow (dilution-adjusted): -3467640.5405405406
Buyback yield (%): 0.5398518520231276
Retained earnings: -9070115.54054054
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.89518948146019
Rule of 40 score: 0
Financial ratios for AMU.AX — annual report dated 2023-12-31
Operating income: -1258725.3424657534
Net income: -1192693.1506849315
Capital expenditures: 523.9726027397261
Depreciation & amortization: 583.5616438356165
Net tangible assets: 15744424.657534247
Owner earnings: -1192633.5616438356
Return on net tangible assets (%): -7.574958041246173
Buffett classification: The Gruesome
Stock price: 0.21917808219178084
Shares outstanding: 130268297
Book value: 15744424.657534247
P/B ratio: 1.8134645201649986
Market cap (USD): 28551955.50684932
Debt to equity: 0
Current ratio: 4.0600084311107985
Quick ratio: 4.0600084311107985
Interest coverage ratio: -1182.586229086229
Free cash flow (dilution-adjusted): -3596106.164383562
Buyback yield (%): 0.5954777700056982
Retained earnings: -10387056.84931507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.994736993221345
Rule of 40 score: 0
Financial ratios for AMU.AX — annual report dated 2024-12-31
Operating income: -1092700
Net income: -1024433.5403726707
Capital expenditures: 2069199.3788819874
Depreciation & amortization: 524.8447204968944
Net tangible assets: 16595754.658385092
Owner earnings: -3093108.074534161
Return on net tangible assets (%): -18.63794770532687
Buffett classification: The Gruesome
Stock price: 0.07453416149068322
Shares outstanding: 130268297
Book value: 16595754.65838509
P/B ratio: 0.585055544961828
Market cap (USD): 9709438.285714284
Debt to equity: 0
Current ratio: 3.6432050525768904
Quick ratio: 3.6432050525768904
Free cash flow (dilution-adjusted): -2935455.900621118
Buyback yield (%): 1.93920935344691
Retained earnings: -10443752.173913043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.584213990220129
Rule of 40 score: 0
Financial ratios for AMU.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 16595754.658385092
Buffett classification: The Gruesome
Stock price: 0.07453416149068322
Shares outstanding: 130268297
Book value: 16595754.65838509
P/B ratio: 0.585055544961828
Market cap (USD): 9709438.285714284
Debt to equity: 0
Current ratio: 3.6432050525768904
Quick ratio: 3.6432050525768904
Buyback yield (%): 0
Retained earnings: -10443752.173913043
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APGN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 164.30769230769232
Shares outstanding: 2997757
Market cap (USD): 492554534.7692308
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APGN.SW — annual report dated 2022-12-31
Total revenue: 337608695.6521739
Gross profit: 130673913.04347825
Operating income: 28085869.56521739
Net income: 25426086.95652174
Capital expenditures: 1941304.347826087
Operating cash flow: 19842391.304347824
Depreciation & amortization: 11780434.782608695
Net tangible assets: 74355434.78260869
Owner earnings: 35265217.39130435
Return on net tangible assets (%): 47.4278948060871
Capex to operating income (%): 6.912032199388521
Buffett classification: The Great
Stock price: 139.32608695652175
P/E ratio: 16.426662630813954
Shares outstanding: 2997757
Book value: 99156521.73913042
P/B ratio: 4.212186401166361
Market cap (USD): 417665752.45652175
Debt to equity: 0
Current ratio: 1.2125438254772107
Quick ratio: 1.1602871612221048
Effective tax rate (%): 19.598542654842923
Interest coverage ratio: 833.5161290322582
COGS to revenue (%): 61.29426915647135
Free cash flow (dilution-adjusted): 13810869.56521739
Buyback yield (%): 0.18035016400910928
Retained earnings: 81948913.04347825
Inventory turnover: 40.54952076677317
Receivables turnover: 8.50842350362964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.952933377527348
FCF margin (%): 4.09079201545396
Rule of 40 score: 4.09079201545396
Financial ratios for APGN.SW — annual report dated 2023-12-31
Total revenue: 387657142.85714287
Gross profit: 153340476.1904762
Operating income: 34122619.04761905
Net income: 31922619.04761905
Capital expenditures: 1625000
Operating cash flow: 41716666.66666667
Depreciation & amortization: 12132142.857142858
Net tangible assets: 75297619.04761904
Owner earnings: 42429761.90476191
Return on net tangible assets (%): 56.34940711462452
Capex to operating income (%): 4.762237030317831
Buffett classification: The Great
Stock price: 184.27380952380952
P/E ratio: 17.30459839753869
Shares outstanding: 2997757
Book value: 99830952.38095239
P/B ratio: 5.5334351645639055
Market cap (USD): 552408102.4166666
Debt to equity: 0
Current ratio: 1.161412784226427
Quick ratio: 1.1105700429321037
Effective tax rate (%): 15.908805820371299
Interest coverage ratio: 4777.166666666667
COGS to revenue (%): 60.44430522798743
Free cash flow (dilution-adjusted): 35666666.66666667
Buyback yield (%): 0.12133024340264882
Retained earnings: 82461904.76190476
Inventory turnover: 38.47263487099297
Receivables turnover: 8.1009030524666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.676723471034197
FCF margin (%): 9.20056996855346
Revenue growth (%): 14.824395179836278
Rule of 40 score: 24.02496514838974
Financial ratios for APGN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 69695555.55555555
Buffett classification: The Gruesome
Stock price: 197.08888888888887
Shares outstanding: 2997757
Book value: 90911111.1111111
P/B ratio: 6.49892613859692
Market cap (USD): 590824596.2888888
Debt to equity: 0
Current ratio: 1.1465257661228845
Quick ratio: 1.1036933983839
Buyback yield (%): 0
Retained earnings: 73993333.33333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for APGN.SW — annual report dated 2024-12-31
Total revenue: 363272222.2222222
Gross profit: 146390000
Operating income: 34680000
Net income: 33638888.88888889
Capital expenditures: 4384444.444444444
Operating cash flow: 45540000
Depreciation & amortization: 10716666.666666666
Net tangible assets: 69695555.55555555
Owner earnings: 39971111.111111104
Return on net tangible assets (%): 57.351018716321775
Capex to operating income (%): 12.642573369216967
Buffett classification: The Great
Stock price: 197.08888888888887
P/E ratio: 17.563736966473986
Shares outstanding: 2997757
Book value: 90911111.1111111
P/B ratio: 6.49892613859692
Market cap (USD): 590824596.2888888
Debt to equity: 0
Current ratio: 1.1465257661228845
Quick ratio: 1.1036933983839
Effective tax rate (%): 18.288305308898547
COGS to revenue (%): 59.70239642753368
Free cash flow (dilution-adjusted): 37000000
Buyback yield (%): 0.02971365049090071
Retained earnings: 73993333.33333333
Inventory turnover: 43.42469410456062
Receivables turnover: 7.672423908197029
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.36209553158706
FCF margin (%): 10.185199345455658
Revenue growth (%): -6.290331826519921
Rule of 40 score: 3.8948675189357367
Financial ratios for APGN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 50105000
Buffett classification: The Gruesome
Stock price: 277.6375
Shares outstanding: 2997757
Market cap (USD): 832289759.0875
Buyback yield (%): 0
Retained earnings: 53452500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.5
Shares outstanding: 309836000
Market cap (USD): 5422130000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AR — annual report dated 2022-12-31
Total revenue: 8299911000
Gross profit: 4592367000
Operating income: 4330479000
Net income: 1998837000
Capital expenditures: 163322000
Operating cash flow: 3051342000
Depreciation & amortization: 719790000
Net tangible assets: 6754558000
Owner earnings: 2555305000
Return on net tangible assets (%): 37.830824755668694
Capex to operating income (%): 3.7714534581509342
Buffett classification: The Great
Stock price: 30.99
P/E ratio: 4.80370217281349
Shares outstanding: 309836000
Book value: 7017154000
P/B ratio: 1.3683350315526779
Market cap (USD): 9601817640
Debt to equity: 0.6598068105673611
Current ratio: 0.44369880371331716
Quick ratio: 0.44369880371331716
Effective tax rate (%): 18.08384161147428
Interest coverage ratio: 34.541037871295025
COGS to revenue (%): 44.66968380745288
SG&A to revenue (%): 8.484584955188074
Free cash flow (dilution-adjusted): 2852577000
Buyback yield (%): 9.099777070958828
Retained earnings: 913896000
Receivables turnover: 11.16820847904862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.08412371902427
FCF margin (%): 34.36876612291385
Rule of 40 score: 34.36876612291385
Financial ratios for AR — annual report dated 2023-12-31
Total revenue: 4278974000
Gross profit: 612471000
Operating income: 333384000
Net income: 297329000
Capital expenditures: 167517000
Operating cash flow: 994721000
Depreciation & amortization: 750093000
Net tangible assets: 6901516000
Owner earnings: 879905000
Return on net tangible assets (%): 12.749445194360195
Capex to operating income (%): 50.24746238571737
Buffett classification: The Good
Stock price: 22.68
P/E ratio: 23.634023186436572
Shares outstanding: 309836000
Book value: 7134214000
P/B ratio: 0.9849831361941204
Market cap (USD): 7027080480
Debt to equity: 0.6316191244052953
Current ratio: 0.32759103940455525
Quick ratio: 0.32759103940455525
Effective tax rate (%): 17.627128035350665
Interest coverage ratio: 2.828404174090099
COGS to revenue (%): 85.68649867935632
SG&A to revenue (%): 11.906615931763081
Free cash flow (dilution-adjusted): 767685000
Buyback yield (%): 1.0723514582545381
Retained earnings: 1051940000
Receivables turnover: 9.649847549974742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7631985948286752
FCF margin (%): 17.940866198298938
Revenue growth (%): -48.445543572696145
Rule of 40 score: -30.504677374397208
Financial ratios for AR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.65
Shares outstanding: 309836000
Market cap (USD): 8876801400
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.05
Shares outstanding: 309836000
Market cap (USD): 10859751800
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AR — annual report dated 2024-12-31
Total revenue: 4118695000
Gross profit: 327333000
Operating income: 52492000
Net income: 93697000
Capital expenditures: 101924000
Operating cash flow: 849288000
Depreciation & amortization: 765827000
Net tangible assets: 7021650000
Owner earnings: 757600000
Return on net tangible assets (%): 10.78948680153525
Capex to operating income (%): 194.17054027280346
Buffett classification: The Gruesome
Stock price: 35.05
P/E ratio: 115.90287629273081
Shares outstanding: 309836000
Book value: 7216533000
P/B ratio: 1.504843364535297
Market cap (USD): 10859751800
Debt to equity: 0.5589194977699125
Current ratio: 0.3510177208116316
Quick ratio: 0.3510177208116316
Interest coverage ratio: 0.444068456182798
COGS to revenue (%): 92.05250692270246
SG&A to revenue (%): 11.514423864840683
Free cash flow (dilution-adjusted): 680902000
Buyback yield (%): 0
Retained earnings: 1109166000
Receivables turnover: 8.439499125046616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4539211490573042
FCF margin (%): 16.531984038633595
Revenue growth (%): -3.7457343746421454
Rule of 40 score: 12.78624966399145
Financial ratios for AR — quarterly report dated 2025-03-31
Total revenue: 1392590000
Gross profit: 421936000
Operating income: 346878000
Net income: 219466000
Capital expenditures: 31011000
Operating cash flow: 457739000
Depreciation & amortization: 187291000
Net tangible assets: 7218374000
Owner earnings: 375746000
Return on net tangible assets (%): 5.205410525971638
Capex to operating income (%): 8.940030788922906
Buffett classification: The Great
Stock price: 40.44
P/E ratio: 14.273017050477065
Shares outstanding: 309836000
Book value: 7408783000
P/B ratio: 1.6912045932510102
Market cap (USD): 12529767840
Debt to equity: 0.5138615883337385
Current ratio: 0.38697044325025953
Quick ratio: 0.38697044325025953
Effective tax rate (%): 19.86372897694493
Interest coverage ratio: 14.844145840465593
COGS to revenue (%): 69.70134784825397
SG&A to revenue (%): 7.5553465126131885
Free cash flow (dilution-adjusted): 411583000
Buyback yield (%): 0.08056015186311705
Retained earnings: 1312366000
Receivables turnover: 2.5147580119436515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.99964328874803
FCF margin (%): 29.555217257053407
Rule of 40 score: 29.555217257053407
Financial ratios for AR — quarterly report dated 2025-06-30
Total revenue: 1204043000
Gross profit: 242658000
Operating income: 171913000
Net income: 166573000
Capital expenditures: 27209000
Operating cash flow: 492358000
Depreciation & amortization: 188531000
Net tangible assets: 7305622000
Owner earnings: 327895000
Return on net tangible assets (%): 4.488255757004675
Capex to operating income (%): 15.827191660898245
Buffett classification: The Great
Stock price: 40.28
P/E ratio: 32.32884262988973
Shares outstanding: 309836000
Book value: 7484507000
P/B ratio: 1.6674704265758586
Market cap (USD): 12480194080
Debt to equity: 0.46652090778991856
Current ratio: 0.30435336637885313
Quick ratio: 0.30435336637885313
Effective tax rate (%): 22.438688228419235
Interest coverage ratio: 8.61546557081287
COGS to revenue (%): 79.84640083452169
SG&A to revenue (%): 9.067034981308806
Free cash flow (dilution-adjusted): 449294000
Buyback yield (%): 0.5999265678086314
Retained earnings: 1435298000
Receivables turnover: 3.013535396513534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5131396426338293
FCF margin (%): 37.31544471418379
Revenue growth (%): -13.539304461471072
Rule of 40 score: 23.776140252712718
Financial ratios for AR — quarterly report dated 2025-09-30
Total revenue: 1133481000
Gross profit: 172401000
Operating income: 103844000
Net income: 85610000
Capital expenditures: 276853000
Operating cash flow: 310090000
Depreciation & amortization: 189724000
Net tangible assets: 7345816000
Owner earnings: -1519000
Return on net tangible assets (%): -0.02067843790261014
Capex to operating income (%): 266.60471476445434
Buffett classification: The Gruesome
Stock price: 33.56
P/E ratio: 22.046259315719954
Shares outstanding: 309836000
Book value: 7517607000
P/B ratio: 1.383165701532416
Market cap (USD): 10398096160
Debt to equity: 0.4749182818415488
Current ratio: 0.3086447721566477
Quick ratio: 0.3086447721566477
Effective tax rate (%): 33.60477741585233
Interest coverage ratio: 5.6956998683633175
COGS to revenue (%): 84.79012881556903
SG&A to revenue (%): 9.529228985752738
Free cash flow (dilution-adjusted): 17736000
Buyback yield (%): 0.4938884889096852
Retained earnings: 1488643000
Receivables turnover: 2.876687401496867
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9009530352072186
FCF margin (%): 1.5647373004046825
Revenue growth (%): -5.8604219284527215
Rule of 40 score: -4.295684628048039
Financial ratios for AR — quarterly report dated 2025-12-31
Total revenue: 1283496000
Gross profit: 271255000
Operating income: 207066000
Net income: 202918000
Capital expenditures: 52709000
Operating cash flow: 370743000
Depreciation & amortization: 188021000
Net tangible assets: 7550827000
Owner earnings: 338230000
Return on net tangible assets (%): 4.479376894742788
Capex to operating income (%): 25.455168883351202
Buffett classification: The Good
Stock price: 34.46
P/E ratio: 15.827854846145751
Shares outstanding: 309836000
Book value: 7715649000
P/B ratio: 1.3838043384295993
Market cap (USD): 10676948560
Debt to equity: 0.45706070869735005
Current ratio: 0.5532979492627284
Quick ratio: 0.5532979492627284
Effective tax rate (%): 25.6342880178843
Interest coverage ratio: 9.357646420824295
COGS to revenue (%): 78.8659255657984
SG&A to revenue (%): 7.817242905314858
Free cash flow (dilution-adjusted): 303723000
Buyback yield (%): 0.0007773756662175021
Retained earnings: 1682295000
Receivables turnover: 2.5304223363944276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.763450369244191
FCF margin (%): 23.663727818396005
Revenue growth (%): 13.234893218324789
Rule of 40 score: 36.8986210367208
Financial ratios for AR — annual report dated 2025-12-31
Total revenue: 5013610000
Gross profit: 1108250000
Operating income: 829701000
Net income: 674567000
Capital expenditures: 387782000
Operating cash flow: 1630930000
Depreciation & amortization: 753567000
Net tangible assets: 7550827000
Owner earnings: 1040352000
Return on net tangible assets (%): 13.777987497263544
Capex to operating income (%): 46.737559675111875
Buffett classification: The Good
Stock price: 34.46
P/E ratio: 15.827854846145751
Shares outstanding: 309836000
Book value: 7715649000
P/B ratio: 1.3838043384295993
Market cap (USD): 10676948560
Debt to equity: 0.45706070869735005
Current ratio: 0.5532979492627284
Quick ratio: 0.5532979492627284
Effective tax rate (%): 24.24289728379644
Interest coverage ratio: 9.914927941492794
COGS to revenue (%): 77.89516934903193
SG&A to revenue (%): 8.431688942697976
Free cash flow (dilution-adjusted): 1182336000
Buyback yield (%): 1.2775560286112309
Retained earnings: 1682295000
Receivables turnover: 9.884371069306384
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.066039498576659
FCF margin (%): 23.58252835781004
Revenue growth (%): 21.728120193410778
Rule of 40 score: 45.31064855122082
Financial ratios for ARCT — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1193000
Buffett classification: The Gruesome
Stock price: 37.01
Shares outstanding: 28423069
Market cap (USD): 1051937783.6899999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARCT — annual report dated 2022-12-31
Total revenue: 205755000
Operating income: 12177000
Net income: 9349000
Capital expenditures: 7726000
Operating cash flow: 31993000
Depreciation & amortization: 1527000
Net tangible assets: 270312000
Owner earnings: 3150000
Return on net tangible assets (%): 1.1653200745804848
Capex to operating income (%): 63.447482959678084
Buffett classification: The Good
Stock price: 16.96
P/E ratio: 51.56222593218526
Shares outstanding: 28423069
Book value: 270312000
P/B ratio: 1.7833290798780668
Market cap (USD): 482055250.24
Debt to equity: 0.3505393767202344
Current ratio: 3.1762505512505514
Quick ratio: 3.1762505512505514
Effective tax rate (%): 12.166478767380685
Interest coverage ratio: 4.057647450849717
COGS to revenue (%): 0
R&D to revenue (%): 71.80919054214965
SG&A to revenue (%): 22.391193409637676
Free cash flow (dilution-adjusted): -6344000
Buyback yield (%): 0
Retained earnings: -338141000
Receivables turnover: 74.44102749638205
Capitalized R&D asset: 147751000
ROCI (R&D-adjusted, %): 23.49076239757418
FCF margin (%): -3.0832786566547594
Rule of 40 score: -3.0832786566547594
Financial ratios for ARCT — annual report dated 2023-12-31
Total revenue: 157748000
Operating income: -78205000
Net income: -29725000
Capital expenditures: 2901000
Operating cash flow: -18099000
Depreciation & amortization: 2957000
Net tangible assets: 278513000
Owner earnings: -29669000
Return on net tangible assets (%): -10.652644580324797
Buffett classification: The Gruesome
Stock price: 31.53
Shares outstanding: 28423069
Book value: 278513000
P/B ratio: 3.217729030853138
Market cap (USD): 896179365.57
Debt to equity: 0.1084904474836004
Current ratio: 4.715144714534877
Quick ratio: 4.715144714534877
Interest coverage ratio: -101.82942708333333
COGS to revenue (%): 0
R&D to revenue (%): 121.79742373912823
SG&A to revenue (%): 33.51611430889774
Free cash flow (dilution-adjusted): -55649000
Buyback yield (%): 0
Retained earnings: -367866000
Receivables turnover: 4.919785429141717
Capitalized R&D asset: 291126170
ROCI (R&D-adjusted, %): 0.09918472712227323
FCF margin (%): -35.27715089890205
Revenue growth (%): -23.332118296031688
Rule of 40 score: -58.60926919493374
Financial ratios for ARCT — quarterly report dated 2024-09-30
Capital expenditures: 80000
Buffett classification: The Gruesome
Stock price: 23.21
Shares outstanding: 28423069
Market cap (USD): 659699431.49
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARCT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.97
Shares outstanding: 28423069
Market cap (USD): 482339480.92999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARCT — annual report dated 2024-12-31
Total revenue: 138389000
Operating income: -95669000
Net income: -80941000
Capital expenditures: 648000
Operating cash flow: -59747000
Depreciation & amortization: 3544000
Net tangible assets: 240978000
Owner earnings: -78045000
Return on net tangible assets (%): -32.38677389637228
Buffett classification: The Gruesome
Stock price: 16.97
Shares outstanding: 28423069
Book value: 240978000
P/B ratio: 2.0015913524471114
Market cap (USD): 482339480.92999995
Debt to equity: 0.11847554548548
Current ratio: 4.672219762097451
Quick ratio: 4.672219762097451
COGS to revenue (%): 0
R&D to revenue (%): 141.01987874758834
SG&A to revenue (%): 38.1699412525562
Free cash flow (dilution-adjusted): -98383000
Buyback yield (%): 0
Retained earnings: -448807000
Receivables turnover: 34.82360342224459
Capitalized R&D asset: 372642940
ROCI (R&D-adjusted, %): -12.109473088688592
FCF margin (%): -71.09163300551344
Revenue growth (%): -12.27210487613155
Rule of 40 score: -83.363737881645
Financial ratios for ARCT — quarterly report dated 2025-03-31
Total revenue: 25477000
Operating income: -16826000
Net income: -14076000
Capital expenditures: 137000
Operating cash flow: -35138000
Depreciation & amortization: 801000
Net tangible assets: 233759000
Owner earnings: -13412000
Return on net tangible assets (%): -5.737533100329826
Buffett classification: The Gruesome
Stock price: 10.59
Shares outstanding: 28423069
Book value: 233759000
P/B ratio: 1.287652243164969
Market cap (USD): 301000300.71
Debt to equity: 0.18248709140610628
Current ratio: 5.642575239328867
Quick ratio: 5.642575239328867
COGS to revenue (%): 0
R&D to revenue (%): 136.9588256074106
SG&A to revenue (%): 44.412607449856736
Free cash flow (dilution-adjusted): -41937000
Buyback yield (%): 0
Retained earnings: -462883000
Receivables turnover: 1.7483530057644798
Capitalized R&D asset: 34893000
ROCI (R&D-adjusted, %): 2.028562513198579
FCF margin (%): -164.60729285237664
Rule of 40 score: -164.60729285237664
Financial ratios for ARCT — quarterly report dated 2025-06-30
Total revenue: 24510000
Operating income: -11616000
Net income: -9180000
Capital expenditures: 0
Operating cash flow: -5755000
Depreciation & amortization: 779000
Net tangible assets: 231053000
Owner earnings: -8401000
Return on net tangible assets (%): -3.635962311677407
Buffett classification: The Gruesome
Stock price: 13.01
Shares outstanding: 28423069
Book value: 231053000
P/B ratio: 1.600429891366916
Market cap (USD): 369784127.69
Debt to equity: 0.1167004972885009
Current ratio: 5.901386649467914
Quick ratio: 5.901386649467914
COGS to revenue (%): 0
R&D to revenue (%): 120.6813545491636
SG&A to revenue (%): 42.17870257037944
Free cash flow (dilution-adjusted): -11955000
Buyback yield (%): 0
Retained earnings: -472063000
Receivables turnover: 1.4246686817019298
Capitalized R&D asset: 52957310
ROCI (R&D-adjusted, %): -1.1173674750492522
FCF margin (%): -48.776009791921666
Revenue growth (%): -3.795580327354084
Rule of 40 score: -52.57159011927575
Financial ratios for ARCT — quarterly report dated 2025-09-30
Total revenue: 14153000
Operating income: -16512000
Net income: -13448000
Capital expenditures: 181000
Operating cash flow: -17151000
Depreciation & amortization: 763000
Net tangible assets: 224559000
Owner earnings: -12866000
Return on net tangible assets (%): -5.729451948040381
Buffett classification: The Gruesome
Stock price: 18.43
Shares outstanding: 28423069
Book value: 224559000
P/B ratio: 2.3327373281409343
Market cap (USD): 523837161.67
Debt to equity: 0.11572459798983786
Current ratio: 7.861446733335437
Quick ratio: 7.861446733335437
COGS to revenue (%): 0
R&D to revenue (%): 164.3821098000424
SG&A to revenue (%): 73.46852257471915
Free cash flow (dilution-adjusted): -23061000
Buyback yield (%): 0
Retained earnings: -485511000
Receivables turnover: 1.7800276694755377
Capitalized R&D asset: 54597620
ROCI (R&D-adjusted, %): -7.3688072637888204
FCF margin (%): -162.940719282131
Revenue growth (%): -42.2562219502244
Rule of 40 score: -205.1969412323554
Financial ratios for ARCT — annual report dated 2025-12-31
Total revenue: 67221000
Operating income: -76260000
Net income: -65783000
Capital expenditures: 230000
Operating cash flow: -74271000
Depreciation & amortization: 3025000
Net tangible assets: 213985000
Owner earnings: -62988000
Return on net tangible assets (%): -29.43570811038157
Buffett classification: The Gruesome
Stock price: 6.13
Shares outstanding: 28423069
Book value: 213985000
P/B ratio: 0.8142318992920065
Market cap (USD): 174233412.97
Debt to equity: 0.11682127251910181
Current ratio: 6.636960884026498
Quick ratio: 6.636960884026498
Interest coverage ratio: -8473.333333333334
COGS to revenue (%): 0
R&D to revenue (%): 166.9299772392556
SG&A to revenue (%): 68.54851906398298
Free cash flow (dilution-adjusted): -99909000
Buyback yield (%): 0
Retained earnings: -514590000
Receivables turnover: 12.081416247304098
Capitalized R&D asset: 306370410
ROCI (R&D-adjusted, %): -24.124713691308003
FCF margin (%): -148.62766099879502
Revenue growth (%): -51.42605264869318
Rule of 40 score: -200.0537136474882
Financial ratios for ARCT — quarterly report dated 2025-12-31
Total revenue: 3081000
Operating income: -31307000
Net income: -29079000
Capital expenditures: 88000
Operating cash flow: -16227000
Depreciation & amortization: 682000
Net tangible assets: 213985000
Owner earnings: -28485000
Return on net tangible assets (%): -13.311680725284484
Buffett classification: The Gruesome
Stock price: 6.13
Shares outstanding: 28423069
Book value: 213985000
P/B ratio: 0.8142318992920065
Market cap (USD): 174233412.97
Debt to equity: 0.11682127251910181
Current ratio: 6.636960884026498
Quick ratio: 6.636960884026498
COGS to revenue (%): 0
R&D to revenue (%): 794.4173969490425
SG&A to revenue (%): 455.2742616033755
Free cash flow (dilution-adjusted): -22956000
Buyback yield (%): 0
Retained earnings: -514590000
Receivables turnover: 0.5537383177570093
Capitalized R&D asset: 49824620
ROCI (R&D-adjusted, %): -11.456452654607412
FCF margin (%): -745.0827653359298
Revenue growth (%): -78.2307637956617
Rule of 40 score: -823.3135291315915
Financial ratios for BBDC3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Operating cash flow: -18311072172.351883
Buffett classification: The Gruesome
Stock price: 1.8035087719298244
Shares outstanding: 5293220781
Market cap (USD): 9546370110.294737
Free cash flow (dilution-adjusted): -18311072172.351883
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBDC3.SA — annual report dated 2022-12-31
Total revenue: 20614969696.969696
Net income: 4063782196.969697
Capital expenditures: 349285037.8787879
Operating cash flow: 9425701325.757576
Depreciation & amortization: 1072579545.4545454
Net tangible assets: 26654378409.090908
Owner earnings: 4787076704.545454
Return on net tangible assets (%): 17.959813697672814
Buffett classification: The Gruesome
Stock price: 1.8292220113851996
P/E ratio: 2.3826266995674223
Shares outstanding: 5293220781
Book value: 30305082765.15149
P/B ratio: 0.31950006666409303
Market cap (USD): 9682475963.726757
Debt to equity: 2.182519500226102
Effective tax rate (%): 12.85391166540287
COGS to revenue (%): 0
SG&A to revenue (%): 36.69537086171567
Free cash flow (dilution-adjusted): 7643080113.636363
Buyback yield (%): 0.43889232566746794
Retained earnings: 24186363.636363637
Receivables turnover: 4.231987659445005
Capitalized R&D asset: 0
FCF margin (%): 37.07538854524661
Rule of 40 score: 37.07538854524661
Financial ratios for BBDC3.SA — annual report dated 2023-12-31
Total revenue: 20275088041.237114
Net income: 2990260824.742268
Capital expenditures: 124330515.46391754
Operating cash flow: -36624329.89690722
Depreciation & amortization: 1344353814.4329898
Net tangible assets: 29736869896.90722
Owner earnings: 4210284123.71134
Return on net tangible assets (%): 14.158464351855777
Buffett classification: The Gruesome
Stock price: 2.5258799171842647
P/E ratio: 4.4711952741121435
Shares outstanding: 5293220781
Book value: 34435901855.670105
P/B ratio: 0.38825874588641973
Market cap (USD): 13370040067.95031
Debt to equity: 2.152425222432086
Effective tax rate (%): -42.06765617679095
COGS to revenue (%): 0
SG&A to revenue (%): 41.333961639807086
Free cash flow (dilution-adjusted): -1921290309.2783506
Buyback yield (%): 0
Retained earnings: -157797938.1443299
Receivables turnover: 3.8428354113906287
Capitalized R&D asset: 0
FCF margin (%): -9.476113274431535
Revenue growth (%): -1.6487128563790376
Rule of 40 score: -11.124826130810572
Financial ratios for BBDC3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.012891344383057
Shares outstanding: 5293220781
Market cap (USD): 10654678293.983425
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBDC3.SA — annual report dated 2024-12-31
Total revenue: 17043717475.728157
Net income: 2838536084.142395
Capital expenditures: 275971682.84789646
Operating cash flow: 8127586569.5792885
Depreciation & amortization: 1089721682.8478966
Net tangible assets: 23407838996.763756
Owner earnings: 3652286084.142395
Return on net tangible assets (%): 15.602833241664642
Buffett classification: The Gruesome
Stock price: 1.4604200323101775
P/E ratio: 2.723349443115669
Shares outstanding: 5293220781
Book value: 27336972815.533997
P/B ratio: 0.2827791400377818
Market cap (USD): 7730325664.012923
Debt to equity: 2.406030307638648
Effective tax rate (%): -3.7965650038809464
COGS to revenue (%): 0
SG&A to revenue (%): 40.91968745822066
Free cash flow (dilution-adjusted): 6825247087.378641
Buyback yield (%): 1.190469696437689
Retained earnings: -406091585.76051784
Receivables turnover: 3.1745313015562866
Capitalized R&D asset: 0
FCF margin (%): 40.0455305428433
Revenue growth (%): -15.937640117452187
Rule of 40 score: 24.107890425391115
Financial ratios for BBDC3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.4604200323101775
Shares outstanding: 5293220781
Market cap (USD): 7730325664.012923
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BBDC3.SA — quarterly report dated 2025-03-31
Total revenue: 5236423263.888889
Net income: 985357986.1111112
Capital expenditures: 281989583.3333334
Operating cash flow: -14455218055.555555
Depreciation & amortization: 290101562.5
Net tangible assets: 25555818576.38889
Owner earnings: 993469965.2777778
Return on net tangible assets (%): 3.887451158366135
Buffett classification: The Gruesome
Stock price: 1.7256944444444444
P/E ratio: 2.317554082816242
Shares outstanding: 5293220781
Book value: 29696324131.944397
P/B ratio: 0.30759637638665194
Market cap (USD): 9134481694.989584
Debt to equity: 2.357871903185833
Effective tax rate (%): 6.387287441459706
COGS to revenue (%): 0
SG&A to revenue (%): 36.70793432142208
Free cash flow (dilution-adjusted): -14883743229.166668
Buyback yield (%): 0.4231162802358733
Retained earnings: -469947743.0555556
Receivables turnover: 0.8503527089985128
Capitalized R&D asset: 0
FCF margin (%): -284.2349153057785
Rule of 40 score: -284.2349153057785
Financial ratios for BBDC3.SA — quarterly report dated 2025-06-30
Total revenue: 5530241240.875912
Net income: 1120303832.1167881
Capital expenditures: 134873905.10948905
Operating cash flow: 7256293613.138685
Depreciation & amortization: 333422992.7007299
Net tangible assets: 27385226824.817516
Owner earnings: 1318852919.708029
Return on net tangible assets (%): 4.815928413318217
Buffett classification: The Gruesome
Stock price: 2.3722627737226274
P/E ratio: 5.963403288771729
Shares outstanding: 5293220781
Book value: 31850764416.05841
P/B ratio: 0.39424204856855527
Market cap (USD): 12556910611.861313
Debt to equity: 2.447461318363549
Effective tax rate (%): -41.80392959400416
COGS to revenue (%): 0
SG&A to revenue (%): 34.24543391508706
Free cash flow (dilution-adjusted): 6729515875.912408
Buyback yield (%): 0
Retained earnings: -493980474.4525547
Receivables turnover: 0.811350193505289
Capitalized R&D asset: 0
FCF margin (%): 121.68575624101614
Revenue growth (%): 5.611043305326986
Rule of 40 score: 127.29679954634312
Financial ratios for BBDC3.SA — quarterly report dated 2025-09-30
Total revenue: 5259225187.969925
Net income: 1046619548.8721803
Capital expenditures: 91332706.76691729
Operating cash flow: 153364849.62406015
Depreciation & amortization: 330009022.55639094
Net tangible assets: 28472249812.030075
Owner earnings: 1285295864.661654
Return on net tangible assets (%): 4.514205491828018
Buffett classification: The Gruesome
Stock price: 2.6710526315789473
P/E ratio: 4.485155241590954
Shares outstanding: 5293220781
Book value: 33109854699.24817
P/B ratio: 0.42701701427096467
Market cap (USD): 14138471296.618422
Debt to equity: 2.465089792480345
Effective tax rate (%): -14.090646069211516
COGS to revenue (%): 0
SG&A to revenue (%): 40.69883217738626
Free cash flow (dilution-adjusted): -227640413.53383458
Buyback yield (%): 0
Retained earnings: -641154135.3383459
Receivables turnover: 0.7875534420329885
Capitalized R&D asset: 0
FCF margin (%): -4.32840210102706
Revenue growth (%): -4.900618998368716
Rule of 40 score: -9.229021099395776
Financial ratios for BBDC3.SA — quarterly report dated 2025-12-31
Total revenue: 5421760401.459853
Net income: 1193739598.5401459
Capital expenditures: 189310036.49635035
Operating cash flow: -3622688686.1313868
Depreciation & amortization: 330196350.3649635
Net tangible assets: 27860491605.839413
Owner earnings: 1334625912.408759
Return on net tangible assets (%): 4.79038895397319
Buffett classification: The Gruesome
Stock price: 2.682226211849192
P/E ratio: 3.266807876940731
Shares outstanding: 5293220781
Book value: 32654859489.051147
P/B ratio: 0.43477803138805027
Market cap (USD): 14197615523.903051
Debt to equity: 2.5073471811435453
Effective tax rate (%): -13.73063732827902
COGS to revenue (%): 0
SG&A to revenue (%): 40.872660107467055
Free cash flow (dilution-adjusted): -4397957481.751824
Buyback yield (%): 0
Retained earnings: -12926094.890510948
Receivables turnover: 0.799348833808147
Capitalized R&D asset: 0
FCF margin (%): -81.11678045690913
Revenue growth (%): 3.0904783058484564
Rule of 40 score: -78.02630215106068
Financial ratios for BBDC3.SA — annual report dated 2025-12-31
Total revenue: 21498948722.627735
Net income: 4365809489.051095
Capital expenditures: 709247810.218978
Operating cash flow: -11411313868.613138
Depreciation & amortization: 1288917335.7664232
Net tangible assets: 27860491605.839413
Owner earnings: 4945479014.59854
Return on net tangible assets (%): 17.750867732577962
Buffett classification: The Gruesome
Stock price: 2.682226211849192
P/E ratio: 3.2520007021627713
Shares outstanding: 5293220781
Book value: 32654859489.051147
P/B ratio: 0.43477803138805027
Market cap (USD): 14197615523.903051
Debt to equity: 2.5073471811435453
Effective tax rate (%): -13.793623693101372
COGS to revenue (%): 0
SG&A to revenue (%): 38.17962445099696
Free cash flow (dilution-adjusted): -13533662043.79562
Buyback yield (%): 0.28613445690649836
Retained earnings: -12926094.890510948
Receivables turnover: 3.1696641527918477
Capitalized R&D asset: 0
FCF margin (%): -62.95034337912245
Revenue growth (%): 26.140020528058173
Rule of 40 score: -36.81032285106428
Financial ratios for BIOG.L — annual report dated 2022-03-31
Total revenue: -275935526.31578946
Net income: -266340789.47368422
Capital expenditures: 0
Operating cash flow: -15975000
Net tangible assets: 518694736.84210527
Owner earnings: -266340789.47368422
Return on net tangible assets (%): -51.34827299293774
Buffett classification: The Gruesome
Stock price: 0.11815789473684211
Shares outstanding: 19107615
Book value: 518694736.8421052
P/B ratio: 0.004352686467550127
Market cap (USD): 2257715.5618421054
Debt to equity: 0.08051840652650377
Free cash flow (dilution-adjusted): -15975000
Buyback yield (%): 404.0530426077919
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOG.L — annual report dated 2023-03-31
Total revenue: -46486419.75308642
Net income: -50985185.18518518
Capital expenditures: 0
Operating cash flow: -7271604.9382716045
Net tangible assets: 407766666.6666666
Owner earnings: -50985185.18518518
Return on net tangible assets (%): -12.503519623604639
Buffett classification: The Gruesome
Stock price: 0.09666666666666665
Shares outstanding: 19107615
Book value: 407766666.6666667
P/B ratio: 0.00452972153192185
Market cap (USD): 1847069.4499999997
Debt to equity: 0.06106736181125128
Free cash flow (dilution-adjusted): -7271604.9382716045
Buyback yield (%): 1397.6093218809297
Receivables turnover: -77.31827515400411
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOG.L — annual report dated 2024-03-31
Total revenue: 98732911.39240506
Net income: 94430379.74683544
Capital expenditures: 0
Operating cash flow: -5368354.4303797465
Net tangible assets: 457350632.9113924
Owner earnings: 94430379.74683544
Return on net tangible assets (%): 20.647261193389554
Buffett classification: The Gruesome
Stock price: 0.12594936708860757
P/E ratio: 0.025485357808310988
Shares outstanding: 19107615
Book value: 457350632.9113924
P/B ratio: 0.005262028392751869
Market cap (USD): 2406592.0158227845
Debt to equity: 0.13029916386895354
Effective tax rate (%): 0.21268342273171123
COGS to revenue (%): 0
SG&A to revenue (%): 4.153899408966781
Free cash flow (dilution-adjusted): -5368354.4303797465
Buyback yield (%): 2309.74239023073
Receivables turnover: 5.376275158533224
Capitalized R&D asset: 0
FCF margin (%): -5.437249195502506
Rule of 40 score: -5.437249195502506
Financial ratios for BIOG.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 472154666.6666667
Buffett classification: The Gruesome
Stock price: 0.1368
Shares outstanding: 19107615
Book value: 472154666.6666666
P/B ratio: 0.005536155663680828
Market cap (USD): 2613921.7320000003
Debt to equity: 0.11020117701544127
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOG.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 287280519.4805195
Buffett classification: The Gruesome
Stock price: 0.09792207792207791
Shares outstanding: 19107615
Book value: 287280519.4805195
P/B ratio: 0.006512997708018769
Market cap (USD): 1871057.3649350647
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOG.L — annual report dated 2025-03-31
Total revenue: -102349350.64935064
Net income: -107351948.05194806
Capital expenditures: 0
Operating cash flow: -6606493.506493506
Net tangible assets: 287280519.4805195
Owner earnings: -107351948.05194806
Return on net tangible assets (%): -37.36833539777402
Buffett classification: The Gruesome
Stock price: 0.09792207792207791
Shares outstanding: 19107615
Book value: 287280519.4805195
P/B ratio: 0.006512997708018769
Market cap (USD): 1871057.3649350647
Debt to equity: 0
Free cash flow (dilution-adjusted): -6606493.506493506
Buyback yield (%): 3781.666141465336
Capitalized R&D asset: 0
Revenue growth (%): -203.66285082242976
Rule of 40 score: -203.66285082242976
Financial ratios for BIOG.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 348479729.7297297
Buffett classification: The Gruesome
Stock price: 0.1358108108108108
Shares outstanding: 19107615
Book value: 348479729.7297298
P/B ratio: 0.007446690479883663
Market cap (USD): 2595020.685810811
Debt to equity: 0.1074667959282598
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.39
Shares outstanding: 2233510540
Market cap (USD): 70109895850.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BN — annual report dated 2022-12-31
Total revenue: 68212499999.99999
Gross profit: 10483823529.411764
Operating income: 10394117647.058823
Net income: 3819852941.1764703
Capital expenditures: 4883088235.294117
Operating cash flow: 6434558823.529411
Depreciation & amortization: 5649264705.882353
Net tangible assets: -17147058823.529411
Owner earnings: 4586029411.764706
Return on net tangible assets (%): -26.745283018867923
Capex to operating income (%): 46.979343520090545
Buffett classification: The Good
Stock price: 20.46
P/E ratio: 11.963189775134556
Shares outstanding: 2233510540
Book value: 104331617647.05884
P/B ratio: 0.43800361461843246
Market cap (USD): 45697625648.4
Debt to equity: 1.508721483392181
Current ratio: 0.6866888754550016
Quick ratio: 0.5695396606943034
Effective tax rate (%): 22.043817527010802
Interest coverage ratio: 1.3208746028779668
COGS to revenue (%): 84.63064170143045
SG&A to revenue (%): 0.13150944819929072
Free cash flow (dilution-adjusted): 1113970588.235294
Buyback yield (%): 1.1038030040922775
Retained earnings: 13239705882.35294
Inventory turnover: 8.620004391743523
Receivables turnover: 4.760069782954487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.888462522384241
FCF margin (%): 1.6330886395239792
Rule of 40 score: 1.6330886395239792
Financial ratios for BN — annual report dated 2023-12-31
Total revenue: 72669696969.69696
Gross profit: 10996212121.21212
Operating income: 10943939393.939394
Net income: 3867424242.424242
Capital expenditures: 5222727272.727272
Operating cash flow: 4899242424.242424
Depreciation & amortization: 6875000000
Net tangible assets: -21309090909.090908
Owner earnings: 5519696969.69697
Return on net tangible assets (%): -25.903014789533565
Capex to operating income (%): 47.72255295583552
Buffett classification: The Good
Stock price: 26.32
P/E ratio: 15.200297078334183
Shares outstanding: 2233510540
Book value: 127456060606.06058
P/B ratio: 0.46122559518369977
Market cap (USD): 58785997412.8
Debt to equity: 1.3891299437714724
Current ratio: 0.5124761340443743
Quick ratio: 0.4350077907257446
Effective tax rate (%): 16.530412034009156
Interest coverage ratio: 0.9318196478101013
COGS to revenue (%): 84.8682290146366
SG&A to revenue (%): 0.07193194612401485
Free cash flow (dilution-adjusted): -1213636363.6363635
Buyback yield (%): 0.8325008691395942
Retained earnings: 13640909090.90909
Inventory turnover: 11.53101983002833
Receivables turnover: 4.733948576222672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.620905301520701
FCF margin (%): -1.6700721404445187
Revenue growth (%): 6.534281795414285
Rule of 40 score: 4.864209654969766
Financial ratios for BN — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1785185185.185185
Buffett classification: The Gruesome
Stock price: 35.06
Shares outstanding: 2233510540
Market cap (USD): 78306879532.40001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BN — annual report dated 2024-12-31
Total revenue: 60144055944.05595
Gross profit: 12636363636.363636
Operating income: 12583216783.216784
Net income: 1295804195.804196
Capital expenditures: 5873426573.426574
Operating cash flow: 5293006993.006993
Depreciation & amortization: 6809090909.090909
Net tangible assets: -18059440559.44056
Owner earnings: 2231468531.4685316
Return on net tangible assets (%): -12.356243949661181
Capex to operating income (%): 46.67667000111148
Buffett classification: The Good
Stock price: 37.94
P/E ratio: 65.395211839864
Shares outstanding: 2233510540
Book value: 115652447552.44757
P/B ratio: 0.7327072766806019
Market cap (USD): 84739389887.59999
Debt to equity: 1.4196864248441496
Current ratio: 0.7768742480189187
Quick ratio: 0.7019458158735427
Effective tax rate (%): 34.638447971781304
Interest coverage ratio: 1.0829972916039723
COGS to revenue (%): 78.98983791828476
SG&A to revenue (%): 0.08836592795851453
Free cash flow (dilution-adjusted): -2519580419.5804195
Buyback yield (%): 0.826062119314871
Retained earnings: 11934265734.265736
Inventory turnover: 12.53894425987449
Receivables turnover: 4.24029975841838
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.303600684022338
FCF margin (%): -4.189242610980629
Revenue growth (%): -17.236401895090008
Rule of 40 score: -21.425644506070636
Financial ratios for BN — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1690209790.2097902
Buffett classification: The Gruesome
Stock price: 37.94
Shares outstanding: 2233510540
Market cap (USD): 84739389887.59999
Free cash flow (dilution-adjusted): 2797202.797202797
Buyback yield (%): 0.11223221601081167
Capitalized R&D asset: 0
Rule of 40 score: 0